Midwest Bio Research Drug Disposition and Toxicology Services
Home About Us Services News Contact Us end
Pic
Overview | Protein Bioanalysis | Small Molecule Bioanalysis | Genetic Toxicology | Program Services
line

Protein Bioanalysis

MBR understands that your drug discovery and development programs are time and budget sensitive and demand the highest quality standards.  As key members of protein-based teams within Big Pharma, we gained extensive experience in the development of protein drugs and biomarkers in support of early-and late-stage development projects.

Our immunoassay team is expert at method development/validation, sample/data handling, and generating regulatory-compliant results in our GLP facility from either small or large sample numbers.  And, we do it on time and within budget.

We guarantee we’ll outperform and outdeliver other laboratories—our track record proves it.

We have key members of protein-based teams within Big Pharma and have gained extensive experience in the development of protein drugs and biomarkers in support of early-and late-stage development projects. Our protein bioanalytical team is expert at method development/validation, sample/data handling, and generating regulatory-compliant results in our GLP facility from either small or large sample numbers.

Contact Us   Protein Bioanalysis Brochure

 

Overview

Our capabilities include:
  • Immunoassays
  • Assay Development, Optimization, and Validation
  • ELISA Format for Drug Quantitation
  • Custom and Specialty Assays
  • Double Antigen Bridges
  • Specific Immunoglobulin Evaluations
  • Anti-drug Antibody Detection, Measurement, and Screening
  • Antibody Titers
  • Epitope Mapping
  • Cell-based Bioassays (Neutralizing Antibodies, Bioactivity)
  • Ligand Binding Assays
  • Formulations Analyses
  • Kinetic Analyses
  • Enzyme Activity Assays
  • PK/TK (Pre-Clinical and Clinical)
  • Biomarker Determination
  • Electrochemiluminescence detection

 
Footer